Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Phase 1/2 Trial of TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Phase 1/2 Trial of TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
Conditions:   Non Hodgkin Lymphoma;   Acute Lymphoblastic Leukemia;   Diffuse Large B Cell Lymphoma;   Primary Mediastinal Large B Cell Lymphoma;   Mantle Cell Lymphoma;   Follicular Lymphoma
Interventions:   Drug: TC-110 T Cells;   Drug: Fludarabine;   Drug: Cyclophosphamide
Sponsor:   TCR2 Therapeutics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 27, 2020 / by / in
Comments